CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)

• Operating margin stands at 0.6 percent, reflecting thin operational profitability.
• Free cash flow margin is recorded at 12.9 percent, showing cash generation ability.
• Gross margin data is unavailable, limiting profitability analysis.

These figures together suggest that while the company generates reasonable free cash flow relative to its revenue, its core operating profitability remains exceptionally thin.

• Balance sheet score is reported at 35, indicating potential leverage or coverage concerns.
• Overall financial quality pillar score stands at 31.
• Specific debt-to-equity and interest coverage metrics are unavailable in the dataset.

These limited indicators point toward structural financial health challenges that weigh down the company's fundamental rating.

• Trailing P/E ratio is elevated at 157.85, while the forward P/E compresses to 25.63.
• Price-to-sales ratio is 3.54, and free cash flow yield sits at 3.6 percent.
• Valuation pillar score is 35.

These metrics indicate that shares are priced at a steep trailing multiple, though expected earnings recovery lowers the forward P/E significantly.